EVO ICL™ Lens in Michigan
Fraser Eye Center is committed to improving eyesight for residents of Detroit and all of Michigan with a variety of vision correction procedures. Our experienced ophthalmologists offer the implantable contact lens procedure with EVO ICL, an innovative procedure that can significantly improve vision for patients who may not be candidates for LASIK because of thin >
Trusted Source
Phakic intraocular lens implantation in United States military warfighters: a retrospective analysis of early clinical outcomes of the Visian ICL
Parkhurst GD, Psolka M, Kezirian GM
Go to Source
corneas.
EVO ICL is also an ideal and highly effective vision correction solution where the eye is not permanently altered.
What is EVO ICL?
EVO ICL is an Implantable Collamer Lens. This is a micro-thin lens implant made of a soft, 100% biocompatible material that also provides UV protection. The EVO ICL can be implanted in the eye during a brief procedure to correct myopia (nearsightedness) or astigmatism. This can be a permanent solution to a patient’s vision needs, but it can also be reversed or upgraded if necessary.
To date, more than 1 million EVO ICL lenses have been implanted across the world. This remarkable lens allows us to provide our patients with vision so clear and sharp that many are able to get rid of their eyeglasses and contact lenses >
Trusted Source
Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for low myopia
Sanders D, Vukich JA
Go to Source
entirely.
How is EVO ICL Different From LASIK?
There are several factors that differentiate EVO ICL from LASIK. Unlike LASIK, the EVO ICL procedure does not use lasers and it does not alter the shape of the cornea. The results of EVO ICL are immediate, and, unlike LASIK, the procedure can be reversed if the patient wishes to have the implantable contact lens removed.
Benefits of EVO ICL
There are so many reasons our patients love the EVO ICL:
- Significantly improved
Trusted Source Visual performance after implantable collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia Igarashi A, Kamiya K, Shimizu K, Komatsu M Go to Source vision
- Virtually painless, 20-30 minute procedure
- Quick recovery
- Biocompatible lens works in harmony with the eye
- Built-in UV protection
- Upgradable and reversible
- Alterations to the cornea are not necessary
- Great for patients with thin
Trusted Source Management of myopic astigmatism with phakic intraocular lens implantation Gimbel HV, Ziémba SL Go to Source corneas
- Does not cause dry eye
Trusted Source Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism Ganesh S, Brar S, Pawar A Go to Source syndrome
- Excellent night
Trusted Source Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life Martínez-Plaza E, López-Miguel A, López-de la Rosa A, McAlinden C, Fernández I, Maldonado MJ Go to Source vision
- Saves patients the maintenance of traditional contact lenses
What To Expect During Your EVO ICL Procedure
The eye surgeon will begin the EVO ICL process by placing numbing drops on the eyes and offering you a mild sedative to ensure your comfort during the procedure. The surgeon will make a very small incision and place the lens in the eye. Results are immediate and unlike a regular contact lens, you will not be able to feel the EVO ICL and other people will not be able to see it.
Recovery After EVO ICL
Patients typically require very little downtime after the EVO ICL procedure and may return to work as soon as two days after surgery. Visual improvement is experienced the same day and studies show a very high satisfaction rate with the results of Implantable Contact Lens (ICL)
Trusted Source
Visual outcomes and patient satisfaction after implantable collamer lens and Toric implantable collamer lens correction for moderate to high myopia and myopic astigmatism
Bamashmus MA, Al-Arabi AH, Alawad MA
Go to Source
procedures.
$1,882/eye
$1,882/eye
$1,882/eye
Varies, depending on lens implant
Quick (24-48 hrs)
2-4 Weeks
1-2 Weeks
1-2 Weeks
10 Minutes
10 Minutes
20-30 Minutes
15-20 Minutes
Yes, up to -12D
Yes, up to -12D
Yes, up to -20D
Yes, up to -26D
Yes, up to +5D
Yes, up to +5D
Yes, up to +10D
Yes, with Monovision
Yes, with Monovision
Yes, with multifocal IOLs
Yes, during recovery
A little, during recovery
Frequently Asked Questions about EVO IC
The ICL procedure, sometimes referred to as an implantable contact lens, can be especially beneficial as a LASIK alternative for patients who do not qualify for laser vision correction due to thin corneas or dry eyes. If you think that an Implantable Collamer Lens (ICL) may be the right vision correction option for you, we encourage you to schedule a consultation at Fraser Eye to learn more and have an evaluation by one of our ICL specialists. You may be a candidate if you:
- Are between the ages of 21 and 45
- Have mild to severe nearsightedness, with or without astigmatism
- Have maintained a stable prescription for at least six months
- Are not pregnant or nursing
- Do not have a history of eye disease such as iritis, glaucoma, or diabetic retinopathy
- Do not have corneal endothelial dystrophy or uncontrolled blepharitis
No. Once implanted, the EVO ICL is completely unobtrusive. You won’t be able to feel or see the lens, which will be positioned behind the colored part of your eye (iris).
EVO ICL is not covered by insurance plans, but this doesn’t mean you can’t afford it. At Fraser Eye Center, it is our goal to provide each of our patients with top-quality vision correction. To do this, we offer convenient and affordable vision care financing with no-interest terms available for those who qualify. To learn more about the cost of EVO ICL, please contact us. We’d be happy to guide you through the financing process.
1Parkhurst GD, Psolka M, Kezirian GM. Phakic intraocular lens implantation in United States military warfighters: a retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011 Jul;27(7):473-81. doi: 10.3928/1081597X-20110106-03. Epub 2011 Jan 17. PMID: 21243974. Available: https://pubmed.ncbi.nlm.nih.gov/21243974/. Accessed November 11, 2021.
2Sanders D, Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for low myopia. Cornea. 2006 Dec;25(10):1139-46. doi: 10.1097/ICO.0b013e31802cbf3c. PMID: 17172886. Available: https://pubmed.ncbi.nlm.nih.gov/17172886/. Accessed November 11, 2021.
3Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual performance after implantable collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Ophthalmol. 2009 Jul;148(1):164-70.e1. doi: 10.1016/j.ajo.2009.02.001. Epub 2009 Apr 17. PMID: 19375059. Available: https://pubmed.ncbi.nlm.nih.gov/19375059/. Accessed November 11, 2021.
4Gimbel HV, Ziémba SL. Management of myopic astigmatism with phakic intraocular lens implantation. J Cataract Refract Surg. 2002 May;28(5):883-6. doi: 10.1016/s0886-3350(01)01098-7. PMID: 11978472. Available: https://pubmed.ncbi.nlm.nih.gov/11978472/. Accessed November 11, 2021.
5Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263. doi: 10.2147/OPTH.S127101. PMID: 28740361; PMCID: PMC5505606. Available: https://pubmed.ncbi.nlm.nih.gov/28740361/. Accessed November 11, 2021.
6Martínez-Plaza E, López-Miguel A, López-de la Rosa A, McAlinden C, Fernández I, Maldonado MJ. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life. Am J Ophthalmol. 2021 Jun;226:117-125. doi: 10.1016/j.ajo.2021.02.005. Epub 2021 Feb 9. PMID: 33577790. Available: https://pubmed.ncbi.nlm.nih.gov/33577790/. Accessed November 11 2021.
7Bamashmus MA, Al-Arabi AH, Alawad MA. Visual outcomes and patient satisfaction after implantable collamer lens and Toric implantable collamer lens correction for moderate to high myopia and myopic astigmatism. Saudi Med J. 2013 Sep;34(9):913-9. PMID: 24043002. Available: https://pubmed.ncbi.nlm.nih.gov/24043002/. Accessed November 11, 2021.